FDA Alert: Hintermann Series H3 Total Ankle Replacement — What to Do Now

Quick takeaway: On June 3, 2026, the FDA updated a safety communication for the Hintermann Series H3 total ankle replacement. If your H3 ankle is working well, FDA does not recommend surgery to remove it. Instead, keep follow-up visits and be alert for warning signs.

The FDA says there is a higher-than-expected long-term risk of device failure, and a higher-than-expected risk of revision surgery (a second surgery to treat problems with the implant). For older adults, noticing ankle changes early matters because walking and balance issues can increase fall risk.

What the FDA is concerned about

In its updated safety communication, the FDA says the Hintermann Series H3 total ankle replacement is linked to:

Elevated long-term risk of device failure
Higher-than-expected risk of revision surgery
Risk of polyethylene (plastic) component fracture

The FDA also notes it is continuing to review data. Your individual risk can vary, so your surgeon/orthopedic clinician is the best person to interpret what the update means for your specific implant and health situation.

If your ankle is working well: what you should do now

What not to do: If your Hintermann Series H3 implant seems to be working well, FDA does not recommend planning self-removal or removal based only on the alert.

What to do instead:

Keep your scheduled follow-up visits.
Know the warning signs that mean you should contact your clinician.
Ask questions at follow-ups (for example, what symptoms would trigger earlier evaluation).

Symptoms that should trigger a call to your clinician

The FDA provides a symptom checklist. Call your health care provider promptly if you have:

New or worsening pain or swelling
Inability to use your ankle or bear weight
Instability (feeling unsteady)
Grinding or other unusual noises from the implanted device
Weakness around your implanted device

Why this matters day-to-day for older adults

Many older adults already face higher fall risk. When an ankle becomes painful, unstable, or weak, it can be harder to walk safely—especially at home, in the bathroom, or when turning or reaching for support.

CDC data show that falls are common among adults age 65 and older. Falls can also lead to injuries that may temporarily limit daily activities and require medical care. The practical takeaway: don’t wait if your ankle symptoms change.

What clinicians may do if symptoms appear

If you call with new or worsening symptoms, clinicians may evaluate you with an approach that can include:

Physical exam
X-rays to assess the ankle
Sometimes CT if there is concern about polyethylene (plastic) component fracture

Testing helps clinicians confirm what’s going on and discuss appropriate next steps.

How to report problems to the FDA

If you experience complications or problems you think may be related to your Hintermann Series H3 implant, FDA encourages reporting. One common route is the FDA’s MedWatch voluntary reporting system.

Bottom line

June 3, 2026: FDA updated its safety communication for the Hintermann Series H3 total ankle replacement.
If it’s working well: FDA does not recommend surgery to remove the implant. Keep follow-up visits.
If symptoms change: contact your orthopedic clinician promptly, especially for pain/swelling, trouble bearing weight, instability, unusual noises, or weakness around the device.

Key sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.